Kerstin Papenfuss

As the Director Pharma at Deep Science Ventures, I lead the creation and development of novel therapeutics for unmet medical needs. With over 10 years of experience in oncology, signal transduction, biotechnology, and pharmaceutical markets, I bring a unique combination of skills and expertise to the role. I have a PhD in Tumour Immunology from Imperial College London and an MBA from Bayes Business School, where I received the Women in Business Award.



I am passionate about applying data analysis, molecular biology, and business acumen to solve complex problems and generate impactful solutions. I have successfully launched and managed Antiverse, a spin-out company that uses AI to predict antibody-antigen binding. I have also established and maintained strategic partnerships with universities, research institutes, and industry players, such as Cell and Gene Therapy Catapult and Abbvie. I have been recognized with multiple awards and certifications for my collaboration and innovation skills. I thrive in highly pressurised and challenging environments, where I can lead and empower a diverse and talented team.